Berry anthocyanin intake and cardiovascular health.

Auteur(s) :
Cassidy A.
Date :
Juin, 2018
Source(s) :
MOLECULAR ASPECTS OF MEDICINE. #61 p76-82
Adresse :
Department of Nutrition & Preventive Medicine, Norwich Medical School, University of East Anglia, James Watson Road, Norwich, NR4 7UQ, United Kingdom. Electronic address: a.cassidy@uea.ac.uk.

Sommaire de l'article

Over half of all cardiovascular (CV) events could be prevented by improved diet. This is reflected in government targets for fruit/vegetable intake, yet these are variable across the world (UK: 5-a-day; USA: 9-a-day), do not identify specific fruits/vegetables, and prove hard to achieve. Mounting evidence from prospective studies, supported by recent randomised controlled trials suggest that the benefits of fruits/vegetables may be due to bioactive substances called flavonoids. Specifically one sub-class of flavonoids, the anthocyanins, responsible for the red/blue hue, are receiving growing attention. Although promising data is emerging from cohort studies, and cell/animal studies, proof of efficacy from longer-term randomised controlled trials, and an understanding of the importance of differential metabolism in relation to clinical efficacy are distinctly lacking. Diet related ill-health are among the leading priorities of our time and simple dietary change, including incorporating a few portions of anthocyanin-rich fruit into our diet could have a significant impact at a public health level.

Source : Pubmed
Retour